Experimental Studies Using Iontophoresis

May 31, 2017

For corneal iontophoresis on humans, the current of 1 mA is completely harmless to the cornea and other sensitive structures of the eye. Experimental studies with application of riboflavin using iontophoresis have shown how this drug molecule penetrates animal corneas (in vivo) and human corneas (ex vivo). The medium-term results (12-18 months) available in the scientific literature (Bikbova et al., Acta Ophthalmology; Vinciguerra et al., JRS; Mastropasqua et al., EUCORNEA and ESCRS Congress 2014) show that iontophoresis is an effective technique for the stabilization of progressive keratoconus (reduction of Kmax, no change of corneal thickness in the follow-up period) with a moderate inflammatory activation and no cases of haze in treated patients. — Visit: www.keratoconuscenter.eu/corneal-iontophoresis — @keratoconuscentereurope — #iontophoresis #eye #treatment #cornea #electric #medicaltreatment #eyecare #ionicmolecules #electrode #ophthalmology #drug #eyetreatment #quicktreatment #safe #safe #effective #trusted #specialists #bestexperts #ophthalmology #harmless #optical #crosslinking #innovative #oculardisease #drugdelivery #transcorneal #ocular #transscleral #moleculartransfe

A post shared by Keratoconus Center Europe (@keratoconuscentereurope) on